Sartorius Aktiengesellschaft (OTCMKTS:SARTF) Stock Rating Upgraded by Cheuvreux

Cheuvreux upgraded shares of Sartorius Aktiengesellschaft (OTCMKTS:SARTF) from a reduce rating to a hold rating in a report published on Wednesday morning, The Fly reports.

A number of other analysts also recently commented on the company. AlphaValue upgraded Sartorius Aktiengesellschaft to a reduce rating in a research note on Tuesday, July 6th. Zacks Investment Research downgraded Sartorius Aktiengesellschaft from a buy rating to a hold rating in a research note on Wednesday, September 22nd. Finally, Societe Generale downgraded Sartorius Aktiengesellschaft from a buy rating to a hold rating in a research note on Thursday, September 30th. One research analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Sartorius Aktiengesellschaft has a consensus rating of Hold and a consensus price target of $640.00.

Sartorius Aktiengesellschaft stock opened at $675.75 on Wednesday. The company has a debt-to-equity ratio of 1.07, a quick ratio of 0.72 and a current ratio of 1.25. The business’s 50-day simple moving average is $767.49 and its two-hundred day simple moving average is $580.96. The company has a market cap of $23.13 billion, a PE ratio of 115.71 and a beta of 0.63. Sartorius Aktiengesellschaft has a fifty-two week low of $359.05 and a fifty-two week high of $947.00.

Sartorius Aktiengesellschaft (OTCMKTS:SARTF) last posted its quarterly earnings results on Wednesday, July 21st. The company reported $2.43 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.20 by $0.23. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $955.90 million. Sartorius Aktiengesellschaft had a return on equity of 30.58% and a net margin of 11.53%. As a group, analysts predict that Sartorius Aktiengesellschaft will post 9.19 EPS for the current fiscal year.

Sartorius Aktiengesellschaft Company Profile

Sartorius AG provides solutions for the biopharmaceutical research and industry. It operates through the following segments: Groups; Bioprocess Solutions (BPS); and Lab Products and Service (LPS). The Group segment produces and markets instruments and consumables as well as related services in its segments BPS and LPS.

Read More: What is a blue-chip stock?

The Fly logo

Analyst Recommendations for Sartorius Aktiengesellschaft (OTCMKTS:SARTF)

Receive News & Ratings for Sartorius Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Aktiengesellschaft and related companies with's FREE daily email newsletter.